Cargando…
Temsirolimus Is Highly Effective as Third-Line Treatment in Chromophobe Renal Cell Cancer
We report unexpectedly high efficacy of temsirolimus as third-line treatment in a patient with metastatic chromophobe renal cell carcinoma. After failure of two sequentially administered tyrosine kinase inhibitors, treatment with temsirolimus resulted in a prolonged partial remission of 14 months, a...
Autores principales: | Zardavas, Dimitrios, Meisel, Alexander, Samaras, Panagiotis, Knuth, Alexander, Renner, Christoph, Pestalozzi, Bernhard C., Stenner-Liewen, Frank |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082484/ https://www.ncbi.nlm.nih.gov/pubmed/21526001 http://dx.doi.org/10.1159/000323804 |
Ejemplares similares
-
Correlation between Cancer Stem Cells and Circulating Tumor Cells and Their Value
por: Toloudi, Maria, et al.
Publicado: (2011) -
Addition of Bevacizumab to Temsirolimus in Kidney Cancer Patients
por: Boyle, H., et al.
Publicado: (2011) -
Two Cases of Unilateral Ashy Dermatosis
por: Imanishi, Hisayoshi, et al.
Publicado: (2011) -
The Perils of a Defective Medical Communication: Fatal Neglected Squamous Cell Carcinoma Arising in Perineal Hidradenitis Suppurativa
por: Pagliarello, Calogero, et al.
Publicado: (2011) -
Burned-Out Testicular Tumor: A Case Report
por: Balalaa, N., et al.
Publicado: (2011)